Cineverse Corp. CNVS
2.02
(0.02)
(0.98%)
as of 25 Sep
- Market cap
- $48.5M
- P/E
- 0.0×
Follow CNVS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.78 | 0.73 | 0.69 | 0.72 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(8.43) | (25.14) | (14.13) | (61.76) | |
P/B ratio |
1.84 | 1.19 | 1.13 | 1.67 | |
Price to Tangible BV |
7.38 | 4.20 | 0.00 | 0.00 | |
EV/Sales |
0.84 | 0.85 | 0.97 | 0.95 | |
EV/EBITDA |
9.50 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(35.30) | (4.32) | (2.40) | (6.16) | |
EV/FCF |
(10.61) | (3.08) | (2.10) | (4.70) | |
Quick Ratio |
0.66 | 0.65 | 0.67 | 0.64 | |
Current Ratio |
0.95 | 0.95 | 0.81 | 0.75 | |
Net Debt/EBITDA |
(1.03) | 10.07 | (7.04) | (10.03) | |
Debt/Assets |
10.73% | 12.08% | 16.87% | 17.71% | |
Debt/Equity |
0.18 | 0.22 | 0.51 | 0.60 | |
Asset Turnover |
1.30 | 0.74 | 0.65 | 0.87 | |
Operating CF/Net income |
1.29 | 1.59 | (2.78) | 0.17 | |
Capex/Depreciation |
(0.54) | 0.01 | 0.16 | (0.13) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
92.31% | 65.64% | 47.20% | 37.97% | |
Intangible Assets out of Total Assets |
0.41 | 0.36 | 0.50 | 0.47 | |
Share Based Compensation of Revenue |
4.00% | 6.31% | 4.04% | 3.10% | |
Graham Net Nets |
(0.02) | (0.04) | (0.80) | (0.64) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.98%) | (25.12%) | (21.25%) | (19.53%) | |
Free Cash Flow Yield |
(10.17%) | (37.60%) | (67.40%) | (28.10%) | |
Revenue per Share |
0.67 | 0.85 | 1.38 | 1.48 | |
Operating CF per Share |
(0.40) | (0.08) | (0.17) | (0.05) | |
Capex per Share |
(0.04) | 0.00 | 0.02 | (0.02) | |
Free Cash Flow per Share |
(0.43) | (0.08) | (0.15) | (0.07) | |
Cash per Share |
0.13 | 0.13 | 0.18 | 0.21 | |
Shareholders Equity per Share |
2.01 | 1.96 | 2.31 | 1.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.01 | 1.96 | 2.31 | 1.94 | |
Free Cash Flow |
(8.01) | (1.60) | (2.75) | (1.42) | |
Working Capital |
(1.27) | (1.41) | (12.23) | (18.88) | |
Capital Expenditures |
(0.66) | 0.01 | 0.44 | (0.43) | |
Net Current Asset Value |
(1.53) | (1.60) | (36.13) | (39.55) | |
EV/EBIT |
27.31 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.00 | (0.02) | 0.01 | |
Net Profit Margin |
(45.95%) | (6.22%) | 4.42% | (18.86%) | |
Price to Operating Income |
25.29 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
14.28 | 25.67 | 27.18 | 29.57 | |
Average Payables |
18.73 | 29.02 | 35.23 | 31.85 | |
Average Assets |
61.27 | 74.56 | 101.40 | 98.35 | |
Average Common Equity |
29.42 | 33.54 | 37.02 | 34.71 |
Columns are period end dates